Rivastigmine is a medication that is licensed for the treatment of mild to moderate dementia in people with Parkinson's or Alzheimer's disease. It is an acetylcholinesterase inhibitor that helps to improve cognitive function by preventing a certain chemical from breaking down in the brain. The medication, which is available by prescription, comes in both capsule and liquid form. Potential side effects include vomiting, dizziness, and diarrhea.
This article refers to the oral forms of rivastigmine (capsules and oral solution). The drug also comes in patch form (see Rivastigmine Patch for more information). The patch provides the benefits of once-daily dosing and a continuous release of the medication.
As with any medicine, side effects are possible with rivastigmine. However, not everyone who takes the drug will experience side effects. In fact, many people tolerate it quite well. If side effects do occur, they are often minor and either require no treatment or can easily be treated by you or your healthcare provider.
Common side effects of rivastigmine include but are not limited to:
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Exelon [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2006 June.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed February 20, 2008.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click